DNA encoding human natural killer cell activating factor II
    1.
    发明授权
    DNA encoding human natural killer cell activating factor II 失效
    编码人类天然杀伤细胞活化因子II的DNA

    公开(公告)号:US06448044B2

    公开(公告)日:2002-09-10

    申请号:US08832488

    申请日:1997-04-03

    IPC分类号: C12P2102

    CPC分类号: C07K16/28 A61K38/00 C07K14/52

    摘要: The invention relates to NKAF II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.

    摘要翻译: 本发明涉及NKAF II多肽,编码多肽的多核苷酸,产生多肽的方法,特别是通过表达多核苷酸,多肽的激动剂和拮抗剂。 本发明还涉及用于应用的这些多核苷酸,多肽,激动剂和拮抗剂的方法,其部分涉及研究,诊断和临床领域。

    Human cystatin F
    2.
    发明授权
    Human cystatin F 失效
    人类半胱氨酸蛋白酶抑制剂F

    公开(公告)号:US5919658A

    公开(公告)日:1999-07-06

    申请号:US832535

    申请日:1997-04-03

    摘要: The invention relates to cystatin F polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.

    摘要翻译: 本发明涉及半胱氨酸蛋白酶抑制剂F多肽,编码多肽的多核苷酸,产生多肽的方法,特别是通过表达多核苷酸,多肽的激动剂和拮抗剂。 本发明还涉及用于应用的这些多核苷酸,多肽,激动剂和拮抗剂的方法,其部分涉及研究,诊断和临床领域。

    Antibodies to natural killer cell activating factor II
    3.
    发明授权
    Antibodies to natural killer cell activating factor II 失效
    自然杀伤细胞激活因子II的抗体

    公开(公告)号:US07309780B2

    公开(公告)日:2007-12-18

    申请号:US11378243

    申请日:2006-03-20

    CPC分类号: C07K16/28 A61K38/00 C07K14/52

    摘要: The invention relates to NKAF II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.

    摘要翻译: 本发明涉及NKAF II多肽,编码多肽的多核苷酸,产生多肽的方法,特别是通过表达多核苷酸,多肽的激动剂和拮抗剂。 本发明还涉及用于应用的这些多核苷酸,多肽,激动剂和拮抗剂的方法,其部分涉及研究,诊断和临床领域。

    Human cystatin F antibodies
    4.
    发明授权
    Human cystatin F antibodies 有权
    人类半胱氨酸蛋白酶抑制剂F抗体

    公开(公告)号:US06576745B1

    公开(公告)日:2003-06-10

    申请号:US09528436

    申请日:2000-03-17

    IPC分类号: C07K1600

    摘要: The invention relates to Cystatin F polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.

    摘要翻译: 本发明涉及半胱氨酸蛋白酶抑制剂F多肽,编码多肽的多核苷酸,产生多肽的方法,特别是通过表达多核苷酸,多肽的激动剂和拮抗剂。 本发明还涉及用于应用的这些多核苷酸,多肽,激动剂和拮抗剂的方法,其部分涉及研究,诊断和临床领域。

    Natural killer cell activating factor II
    6.
    发明授权
    Natural killer cell activating factor II 失效
    自然杀伤细胞激活因子II

    公开(公告)号:US07078482B2

    公开(公告)日:2006-07-18

    申请号:US10192611

    申请日:2002-07-11

    CPC分类号: C07K16/28 A61K38/00 C07K14/52

    摘要: The invention relates to NKAF II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.

    摘要翻译: 本发明涉及NKAF II多肽,编码多肽的多核苷酸,产生多肽的方法,特别是通过表达多核苷酸,多肽的激动剂和拮抗剂。 本发明还涉及用于应用的这些多核苷酸,多肽,激动剂和拮抗剂的方法,其部分涉及研究,诊断和临床领域。

    DR3 antibodies
    7.
    发明授权
    DR3 antibodies 失效
    DR3抗体

    公开(公告)号:US07708996B2

    公开(公告)日:2010-05-04

    申请号:US12046107

    申请日:2008-03-11

    摘要: The present invention relates to novel Death Domain Containing Receptor (DR3 and DR3-V1) proteins that are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR3 and DR3-V1 proteins. DR3 and DR3-V1 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are antibodies and fragments thereof that bind to polypeptides of the invention. The invention further relates to screening methods for identifying agonists and antagonists of DR3 and DR3-V1 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新型死亡域含有受体(DR3和DR3-V1)蛋白。 特别地,提供编码人DR3和DR3-V1蛋白的分离的核酸分子。 还提供DR3和DR3-V1多肽,载体,宿主细胞以及用于制备它们的重组方法也是如此。 还提供了结合本发明多肽的抗体及其片段。 本发明还涉及用于鉴定DR3和DR3-V1活性的激动剂和拮抗剂的筛选方法。

    Death domain containing receptors
    8.
    发明授权
    Death domain containing receptors 有权
    含有受体的死亡域

    公开(公告)号:US07357927B2

    公开(公告)日:2008-04-15

    申请号:US10189189

    申请日:2002-07-05

    摘要: The present invention relates to novel Death Domain Containing Receptor (DR3 and DR3-V1) proteins that are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR3 and DR3-V1 proteins. DR3 and DR3-V1 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are antibodies and fragments thereof that bind to polypeptides of the invention. The invention further relates to screening methods for identifying agonists and antagonists of DR3 and DR3-V1 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新型死亡域含有受体(DR3和DR3-V1)蛋白。 特别地,提供编码人DR3和DR3-V1蛋白的分离的核酸分子。 还提供DR3和DR3-V1多肽,载体,宿主细胞以及用于制备它们的重组方法也是如此。 还提供了结合本发明多肽的抗体及其片段。 本发明还涉及用于鉴定DR3和DR3-V1活性的激动剂和拮抗剂的筛选方法。

    Death domain containing receptor 5
    10.
    发明授权
    Death domain containing receptor 5 有权
    含有受体5的死亡域

    公开(公告)号:US06743625B2

    公开(公告)日:2004-06-01

    申请号:US09874138

    申请日:2001-06-06

    IPC分类号: C07K14705

    摘要: The present invention relates to novel Death Domain Containing Receptor-5 (DR5) proteins which are members of the tumor necrosis factor (TNF) receptor family, and have now been shown to bind TRAIL. In particular, isolated nucleic acid molecules are provided encoding the human DR5 proteins. DR5 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying antagonists and antagonists of DR5 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族的成员的新的含有死亡域的受体-5(DR5)蛋白,现在已经显示结合TRAIL。 特别地,提供编码人DR5蛋白的分离的核酸分子。 还提供了DR5多肽,载体,宿主细胞以及用于制备它们的重组方法。 本发明还涉及用于鉴定DR5活性的拮抗剂和拮抗剂的筛选方法。